Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation
Recruiting
Phase 1
Interventional Study
Repetitive Head Impacts
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 30 – 70
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 30 (estimated)
- Sponsor
- Pravat Mandal · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to test whether the gamma - glutamylcystiene (GGC) oral supplement can reach the brain and subsequently increase antioxidant glutathione (GSH) level in people with repetitive head impact (RHI). This will reduce the oxidative stress related injury in people with RHI.This unique study's main objective is to test the:
1. Change in GSH in brain and blood levels thro…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Retired NFL player, retired Navy SEAL/army personnel with combat experience exposed to repetitive head impact;
* Memory and behavioral complaint per self- or informant-report;
* Age (30 to 70 years of age) years;
* Able to read and write in English and to give consent to parti…
Contacts